• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC EUROPE SARL AZURE XT DR MRI SURESCAN; PULSE GENERATOR, PERMANENT, IMPLANTABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC EUROPE SARL AZURE XT DR MRI SURESCAN; PULSE GENERATOR, PERMANENT, IMPLANTABLE Back to Search Results
Model Number W1DR01
Device Problem Battery Problem (2885)
Patient Problem Exit Block (2628)
Event Date 09/11/2019
Event Type  Injury  
Manufacturer Narrative
Concomitant medical products: etlw1610c124e stent, implanted: (b)(6) 2017; esbf2314c103e stent, implanted: (b)(6) 2017; etlw1620c93e, implanted: (b)(6) 2017; etlw1616c82e stent, implanted: (b)(6) 2017.If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was reported that the patient experienced intermittent heart block.The right ventricular (rv) his bundle lead exhibited high thresholds and the implantable pulse generator (ipg) battery longevity had significantly decreased.The lead and ipg were explanted and replaced.The patient is a participant in the post approval clinical surveillance product surveillance registry.No patient complications have been reported as a result of this event.
 
Manufacturer Narrative
Corrected: b5.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event Description
It was reported that the patient experienced intermittent heart block.The right ventricular (rv) his bundle lead exhibited increasing thresholds and the implantable pulse generator (ipg) battery longevity had significantly decreased.The lead and ipg were explanted and replaced.The patient is a participant in the post approval clinical surveillance product surveillance registry.No patient complications have been reported as a result of this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AZURE XT DR MRI SURESCAN
Type of Device
PULSE GENERATOR, PERMANENT, IMPLANTABLE
Manufacturer (Section D)
MEDTRONIC EUROPE SARL
route du molliau 31
case postale
tolochenaz vaud 1131
CH  1131
MDR Report Key10183056
MDR Text Key196058017
Report Number9614453-2020-01910
Device Sequence Number1
Product Code NVZ
UDI-Device Identifier00643169871939
UDI-Public00643169871939
Combination Product (y/n)N
PMA/PMN Number
P980035
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,study
Type of Report Initial,Followup
Report Date 07/30/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date04/14/2020
Device Model NumberW1DR01
Device Catalogue NumberW1DR01
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 05/29/2020
Initial Date FDA Received06/23/2020
Supplement Dates Manufacturer Received07/30/2020
Supplement Dates FDA Received07/30/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
383069 LEAD, 5076-52 LEAD; 383069 LEAD, 5076-52 LEAD
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age83 YR
Patient Weight81
-
-